Answers are grounded in this paper and cite their sources.
Astrocytes and microglia interact through direct contact, reciprocal signaling, and factors released into the extracellular environment. These interactions may influence how the brain responds to amyloid-beta (Aβ) in Alzheimer's disease (AD). Habib et al. identified a disease-associated astrocyte (DAA) state in 5xFAD mice with changes in genes related to inflammation, complement, endocytosis, lysosomal activity, and amyloid biology. Astrocytic PD-L1 and microglial PD-1 may suppress inflammatory signaling and support microglial Aβ uptake. Based on these findings, this proposal uses a two-part experimental design. Experiment 1 first tests whether DAA-conditioned medium or recombinant PD-L1 changes the resulting microglial phenotype; experiment 2 compares four culture conditions and the effects of Aβ protein on microglial phenotype, as well as the effects of different culture conditions on astrocytes. The predicted pattern is that DAA-conditioned medium and PD-L1 will improve several microglial readouts after prior Aβ exposure, while direct co-culture will preserve more function during ongoing Aβ stress than medium transfer alone. This prediction provides new insights to future therapeutic approaches, since it establishes the importance of PD-L1 in the regulation of microglial inflammation, and the effects of the interactions between microglia and astrocytes.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: